Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13G/A for NeuroPace Inc Common Stock, par value $0.001 per share (NPCE).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
ORBIMED ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for NeuroPace Inc Common Stock, par value $0.001 per share (NPCE)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- OrbiMed Advisors LLC
- Symbol
- NPCE
- Shares outstanding
- 32,441,286 shares
- Disclosed Ownership
- 3,406,335 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 20:15:55 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 10% ownership in NeuroPace Inc Common Stock, par value $0.001 per share (NPCE) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 20:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 10% | 3,406,335 | 0 | 3,406,335 | /s/ Carl L. Gordon | Carl L. Gordon / Member | |
| OrbiMed Capital GP VI LLC | 10% | 3,406,335 | 0 | 3,406,335 | /s/ Carl L. Gordon | Carl L. Gordon / Member of OrbiMed Advisors LLC |